GlassScriptPhysician profile
Michelle Liddy
NPI 1487745345
$1,474.91
in general payments reported to CMS, 2019-2025
21 companies · $439 in 2025
The $439 reported for 2025 was more than what 94% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $189 · 2022: $219 · 2023: $432 · 2024: $196 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $248.74 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $234.05 | 2021-2025 | |
| Exeltis, USA INC. | $178.66 | 2021-2025 | Slynd |
| Abbvie INC. | $137.33 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $83.89 | 2023-2025 | Myfembree |
| Organon LLC | $80.40 | 2022-2025 | Nexplanon |
| Evofem Biosciences, INC. | $68.08 | 2021-2025 | Phexxi, Solosec, Phexx |
| Agile Therapeutics, INC. | $61.61 | 2021-2022 | |
| Exact Sciences Corporation | $53.49 | 2025 | Cologuard Collection Kit |
| Millicent US INC | $50.14 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Hologic Sales and Service, LLC | $44.53 | 2023-2025 | Myosure Tissue Removal Device, Novasure |
| Radius Health, INC. | $34.40 | 2024-2025 | |
| Astellas Pharma US INC | $33.00 | 2023-2024 | Veozah |
| Therapeuticsmd, INC. | $32.22 | 2021-2022 | |
| Shield Therapeutics INC | $29.15 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mycovia Pharmaceuticals, INC. | $20.72 | 2023 | Vivjoa |
| Daiichi Sankyo INC. | $19.75 | 2024 | Injectafer |
| Merck Sharp & Dohme LLC | $19.17 | 2021 | |
| Optumhealth Care Solutions, LLC | $18.59 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Coopersurgical, INC. | $13.61 | 2023 | Paragard T 380a |
| Pfizer INC. | $13.38 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Liddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.